HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Tyrosol, a phenolic compound, ameliorates hyperglycemia by regulating key enzymes of carbohydrate metabolism in streptozotocin induced diabetic rats.

Abstract
The present study was designed to evaluate the effects of tyrosol, a phenolic compound, on the activities of key enzymes of carbohydrate metabolism in the control and streptozotocin-induced diabetic rats. Diabetes mellitus was induced in rats by a single intraperitoneal injection of streptozotocin (40 mg/kg body weight). Experimental rats were administered tyrosol 1 ml intra gastrically at the doses of 5, 10 and 20mg/kg body weight and glibenclamide 1 ml at a dose of 600 μg/kg body weight once a day for 45 days. At the end of the experimental period, diabetic control rats exhibited significant (p<0.05) increase in plasma glucose, glycosylated hemoglobin with significant (p<0.05) decrease in plasma insulin, total hemoglobin and body weight. The activities of key enzymes of carbohydrate metabolism such as phosphoenolpyruvate carboxykinase, fructose-1,6-bisphosphatase and glucose-6-phosphatase were significantly (p<0.05) increased and the activities of hexokinase and glucose-6-phosphate dehydrogenase were significantly (p<0.05) decreased in the liver and kidney of diabetic control rats. Further, antioxidants were lowered in diabetic control rats. A significant (p<0.05) decline in glycogen level in the liver and muscle and glycogen synthase activity in the liver and a significant (p<0.05) increase in the activity of liver glycogen phosphorylase were observed in diabetic control rats compared to normal control rats. Oral administration of tyrosol to diabetic rats reversed all the above mentioned biochemical parameters to near normal in a dose dependent manner. Tyrosol at a dose of 20mg/kg body weight showed the highest significant effect than the other two doses. Immunohistochemical staining of pancreas revealed that tyrosol treated diabetic rats showed increased insulin immunoreactive β-cells, which confirmed the biochemical findings. The observed results were compared with glibenclamide, a standard oral hypoglycemic drug. The results of the present study suggest that tyrosol decreases hyperglycemia, by its antioxidant effect.
AuthorsRamasamy Chandramohan, Leelavinothan Pari, Ayyasamy Rathinam, Bashir Ahmad Sheikh
JournalChemico-biological interactions (Chem Biol Interact) Vol. 229 Pg. 44-54 (Mar 05 2015) ISSN: 1872-7786 [Electronic] Ireland
PMID25641191 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
CopyrightCopyright © 2015 Elsevier Ireland Ltd. All rights reserved.
Chemical References
  • Antioxidants
  • Blood Glucose
  • Carbohydrates
  • Hypoglycemic Agents
  • 4-hydroxyphenylethanol
  • Fructose-Bisphosphatase
  • Glucose-6-Phosphatase
  • Phenylethyl Alcohol
Topics
  • Animals
  • Antioxidants (therapeutic use)
  • Blood Glucose (analysis)
  • Body Weight (drug effects)
  • Carbohydrate Metabolism (drug effects)
  • Carbohydrates (urine)
  • Diabetes Mellitus, Experimental (complications, drug therapy, enzymology, pathology)
  • Eating (drug effects)
  • Fructose-Bisphosphatase (metabolism)
  • Glucose Tolerance Test
  • Glucose-6-Phosphatase (metabolism)
  • Hyperglycemia (complications, drug therapy, enzymology, pathology)
  • Hypoglycemic Agents (therapeutic use)
  • Male
  • Pancreas (drug effects, metabolism, pathology)
  • Phenylethyl Alcohol (analogs & derivatives, therapeutic use)
  • Rats
  • Rats, Wistar

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: